Found: 23
Select item for more details and to access through your institution.
BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1136, doi. 10.1007/s10637-015-0280-0
- By:
- Publication type:
- Article
Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 10, p. 605, doi. 10.1159/000449024
- By:
- Publication type:
- Article
First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 6, p. 553, doi. 10.1007/s40261-018-0629-1
- By:
- Publication type:
- Article
Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer.
- Published in:
- Molecular Diagnosis & Therapy, 2016, v. 20, n. 4, p. 401, doi. 10.1007/s40291-016-0213-4
- By:
- Publication type:
- Article
Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 2, p. 339, doi. 10.1159/000500481
- By:
- Publication type:
- Article
Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation р.T632I.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 1, p. 109, doi. 10.1159/000495782
- By:
- Publication type:
- Article
Agnostic Administration of Targeted Anticancer Drugs: Looking for a Balance between Hype and Caution.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 4094, doi. 10.3390/ijms25074094
- By:
- Publication type:
- Article
Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10530, doi. 10.3390/ijms241310530
- By:
- Publication type:
- Article
KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4868, doi. 10.3390/ijms24054868
- By:
- Publication type:
- Article
Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 4586, doi. 10.3390/ijms23094586
- By:
- Publication type:
- Article
Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 20, p. 10931, doi. 10.3390/ijms222010931
- By:
- Publication type:
- Article
Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 2, p. 307, doi. 10.1007/s10549-023-07135-3
- By:
- Publication type:
- Article
Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and is accompanied by a border-line increase of chromosomal instability.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 192, n. 2, p. 283, doi. 10.1007/s10549-022-06517-3
- By:
- Publication type:
- Article
Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 1, p. 229, doi. 10.1007/s10549-020-05827-8
- By:
- Publication type:
- Article
Exome sequencing study of Russian breast cancer patients suggests a predisposing role for USP39.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 3, p. 731, doi. 10.1007/s10549-019-05492-6
- By:
- Publication type:
- Article
Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
- Published in:
- 2014
- By:
- Publication type:
- Report
Small fraction of testicular cancer cases may be causatively related to CHEK2 inactivating germ-line mutations: evidence for somatic loss of the remaining CHEK2 allele in the tumor tissue.
- Published in:
- Familial Cancer, 2021, v. 20, n. 1, p. 49, doi. 10.1007/s10689-020-00190-5
- By:
- Publication type:
- Article
Strong founder effect for BRCA1 c.3629_3630delAG pathogenic variant in Chechen patients with breast or ovarian cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 3167, doi. 10.1002/cam4.5159
- By:
- Publication type:
- Article
Evidence for angiogenesis-independent contribution of VEGFR1 (FLT1) in gastric cancer recurrence.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Evidence for angiogenesis-independent contribution of VEGFR1 ( FLT1) in gastric cancer recurrence.
- Published in:
- Medical Oncology, 2013, v. 30, n. 3, p. 1, doi. 10.1007/s12032-013-0644-2
- By:
- Publication type:
- Article
Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patients.
- Published in:
- Medical Oncology, 2013, v. 30, n. 3, p. 1, doi. 10.1007/s12032-013-0686-5
- By:
- Publication type:
- Article
Revisiting multiple erroneous genetic testing results and clinical misinterpretations in a patient with Li-Fraumeni syndrome: lessons for translational medicine.
- Published in:
- Hereditary Cancer in Clinical Practice, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s13053-020-00157-8
- By:
- Publication type:
- Article
High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 10, p. 2352, doi. 10.1002/ijc.28569
- By:
- Publication type:
- Article